F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Covid Vaccine

Federal regulators concluded that the risk of developing the syndrome was low, and that the benefits of the vaccine still strongly outweigh it.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Johnson & Guillain-Barre Syndrome Vaccination and Immunization Drugs (Pharmaceuticals) Coronavirus (2019-nCoV) Disease Rates Regulation and Deregulation of Industry Food and Drug Administration Centers for Disease Control and Prevention Source Type: news